MSP Act – Proposed Rule on Civil Money Penalties
Pressented By: DRI's Medicare Secondary Payer Act Task Force
CMS has finally issued its proposed rule on civil money penalties for failing to meet Section 111 reporting obligations. Join us to learn what this means for you and your practice, including implications on industry if passed in its current form and DRI’s Comments submitted in response to the proposed rule.
Who Should Attend:
What Will You Learn?:
Judith L. O’Grady is a partner with Pepper Hamilton LLP, resident in the Washington office. Ms. O’Grady is a member of the firm’s Health Effects Litigation Practice Group. She has extensive experience defending pharmaceutical and medical device manufacturers in products liability actions. Ms. O’Grady also has significant experience counseling clients regarding federal regulations governing the pharmaceutical and medical device industries, the Medicare Secondary Payer Act and Section 111 of the Medicare, Medicaid and SCHIP Extension Act of 2007.
John P. Morgenstern is a shareholder at Philadelphia-based Deasey, Mahoney & Valentini where he defends matters of governmental liability, employment law, product liability, and professional liability. John routinely advises clients on MSP Act compliance in cases involving major catastrophic injuries and has written and lectured extensively on the subject. John is a member of DRI’s MSP Act Task Force as well as the Governmental Liability, Employment Law, Professional Liability and Product Liability committees.